The Tuttlingen-based KLS Martin Group is very satisfied with the course of the past financial year. The family-run medical technology company was able to generate record sales of EUR 328 million in 2021. Compared to 2020, this corresponds to growth of around 13%.
As in previous years, the USA, Germany, Italy, China, Great Britain, Spain and Australia made a significant contribution to the overall turnover. In the USA, the Group's largest market, growth of over 20% was generated and a significant increase in sales was also achieved in some European markets.
In the summer of 2021, after an intensive planning and construction phase, the new production building "Building 70" in Mühlheim was occupied. The production building in the USA was expanded and a new, larger office with a showroom was opened in Shanghai, China.
In addition, the KLS Martin Group was able to look back on its 125th anniversary last year. Unfortunately, this anniversary could not be celebrated as planned due to Corona.
The topic of Corona was also omnipresent in 2021. "Throughout the year, many employees had the opportunity to work remotely. A majority of the meetings are held online and the parents of dependent children have been given special leave to look after the children. In addition, the group of companies organized and carried out several vaccination campaigns," reports Karl Leibinger, managing partner.
“More courses and events took place again last year, including Arab Health in June in Dubai, the German Congress for Orthopedics and Trauma Surgery (DKOU) in October in Berlin, and various master class courses for users of patient-specific implants in Berlin and Bruges ' says Michael Martin, Managing Director. He assumes that this trend will continue in 2022. At the same time, the successful webinar series was continued and more than 200 webinars with over 24,000 participants were held last year.
Despite the tense situation on the procurement markets, the KLS Martin Group is looking positively into 2022, for which it is again planning double-digit sales growth. “We continue to expect above-average growth in the area of patient-specific implants. In addition, planning has started for an expansion of the logistics building and a new company headquarters in Tuttlingen, as well as another new building in the USA," explains managing partner Christian Leibinger.
At the same time, work is being done on simplifying the corporate structure as part of the “KLS ONE” project. The aim of the project is to turn the five German companies of the KLS Martin Group into one company in the medium term. After KLS Martin Medical GmbH & Co. KG had already been integrated into Karl Leibinger Medizintechnik in 2021, the integration of the two Mühlheim-based companies Rudolf Buck GmbH and Mondeal Medical Systems GmbH into Karl Leibinger Medizintechnik has already started.
To the original article
